|
1
|
PointState Capital
New York
|
$69M
|
+$1.95M
|
+92,280
|
+3%
|
|
|
2
|
Palo Alto Investors
Palo Alto,
California
|
$66.5M
|
-$1.83M
|
-86,354
|
-2%
|
|
|
3
|
Redmile Group
San Francisco,
California
|
$59.5M
|
+$27.6M
|
+1,303,400
|
+73%
|
|
|
4
|
Vanguard Group
Malvern,
Pennsylvania
|
$42.9M
|
+$24.4K
|
+1,153
|
+0.1%
|
|
|
5
|
HealthCor Management
New York
|
$38.4M
|
+$10.1M
|
+475,000
|
+31%
|
|
|
6
|
PFM Health Sciences
San Francisco,
California
|
$36M
|
-$4.32M
|
-204,056
|
-10%
|
|
|
7
|
State Street
Boston,
Massachusetts
|
$34.5M
|
+$6.64M
|
+313,893
|
+21%
|
|
|
8
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$30M
|
-$387K
|
-18,290
|
-1%
|
|
|
9
|
Fidelity Investments
Boston,
Massachusetts
|
$27.6M
|
-$27.3M
|
-1,290,854
|
-47%
|
|
|
10
|
OppenheimerFunds
New York
|
$23.9M
|
+$24.3K
|
+1,150
|
+0.1%
|
|
|
11
|
BlackRock Fund Advisors
San Francisco,
California
|
$23M
|
+$951K
|
+44,935
|
+4%
|
|
|
12
|
NEA Management Company
Timonium,
Maryland
|
$21.9M
|
–
|
–
|
–
|
|
|
13
|
|
$20.7M
|
+$2.87M
|
+135,402
|
+14%
|
|
|
14
|
Antipodean Advisors
New York
|
$20.4M
|
-$4.42M
|
-208,757
|
-16%
|
|
|
15
|
|
$19.6M
|
-$17.9M
|
-848,103
|
-45%
|
|
|
16
|
BlackRock Institutional Trust
San Francisco,
California
|
$15.8M
|
+$1.15M
|
+54,476
|
+7%
|
|
|
17
|
|
$12.7M
|
-$1.45M
|
-68,700
|
-9%
|
|
|
18
|
Lansdowne Partners (UK)
London,
United Kingdom
|
$10.7M
|
–
|
–
|
–
|
|
|
19
|
BB Biotech
Schaffhausen,
Switzerland
|
$10.1M
|
–
|
–
|
–
|
|
|
20
|
Renaissance Technologies
New York
|
$9.9M
|
+$10.9M
|
+515,400
|
New
|
|
|
21
|
Visium Asset Management
New York
|
$9.6M
|
-$782K
|
-36,967
|
-7%
|
|
|
22
|
Versant Venture Management
San Francisco,
California
|
$7.82M
|
–
|
–
|
–
|
|
|
23
|
Northern Trust
Chicago,
Illinois
|
$6.83M
|
+$191K
|
+9,037
|
+3%
|
|
|
24
|
Westfield Capital Management
Boston,
Massachusetts
|
$6.67M
|
+$7.36M
|
+347,660
|
New
|
|
|
25
|
Millennium Management
New York
|
$5.58M
|
-$18.7M
|
-883,462
|
-75%
|
|
